133 related articles for article (PubMed ID: 37094798)
1. Optimization of laboratory diagnosis of heparin-induced thrombocytopenia using HemosIL-AcuStar-HIT-IgG assay.
Tucker CM; Rhoades R; Sharma R; Gong JZ
Lab Med; 2024 Jan; 55(1):34-39. PubMed ID: 37094798
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
3. Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia.
Marchetti M; Barelli S; Zermatten MG; Monnin-Respen F; Matthey-Guirao E; Nicolas N; Gomez F; Goodyer M; Gerschheimer C; Alberio L
Blood; 2020 Apr; 135(14):1171-1184. PubMed ID: 31945147
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.
Althaus K; Hron G; Strobel U; Abbate R; Rogolino A; Davidson S; Greinacher A; Bakchoul T
Thromb Res; 2013 Mar; 131(3):e85-90. PubMed ID: 23351665
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two new automated chemiluminescent assays (HemosIL® AcuStar HIT-IgG and HemosIL® AcuStar HIT-Ab) for the detection of heparin-induced antibodies in the diagnosis of heparin-induced thrombocytopenia.
Van Hoecke F; Devreese K
Int J Lab Hematol; 2012 Aug; 34(4):410-6. PubMed ID: 22405611
[TBL] [Abstract][Full Text] [Related]
6. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
7. Clinical validation of immunoassay HemosIL® AcuStar HIT-IgG (PF4-H) in the diagnosis of Heparin-induced thrombocytopenia.
Marashi-Sabouni Z; Vayne C; Ibrahim-Kosta M; Guidon C; Loundou A; Guery EA; Morange PE; Camoin-Jau L
J Thromb Thrombolysis; 2021 Aug; 52(2):601-609. PubMed ID: 33386560
[TBL] [Abstract][Full Text] [Related]
8. Profile of Instrumentation Laboratory's HemosIL® AcuStar HIT-Ab(PF4-H) assay for diagnosis of heparin-induced thrombocytopenia.
Nagler M; Cuker A
Expert Rev Mol Diagn; 2017 May; 17(5):419-426. PubMed ID: 28271738
[TBL] [Abstract][Full Text] [Related]
9. Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry.
Minet V; Baudar J; Bailly N; Douxfils J; Laloy J; Lessire S; Gourdin M; Devalet B; Chatelain B; Dogné JM; Mullier F
Thromb Res; 2014 Jun; 133(6):1074-8. PubMed ID: 24485951
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: a retrospective study.
Minet V; Bailly N; Douxfils J; Osselaer JC; Laloy J; Chatelain C; Elalamy I; Chatelain B; Dogné JM; Mullier F
Thromb Res; 2013 Sep; 132(3):352-9. PubMed ID: 23803389
[TBL] [Abstract][Full Text] [Related]
11. [New stream for the measurement of anti-platelet factor 4/heparin antibodies].
Sakata T
Rinsho Byori; 2013 Feb; 61(2):137-43. PubMed ID: 23672091
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopenia.
Vianello F; Sambado L; Scarparo P; Lombardi A; Bernardi D; Plebani M; Fabris F
Clin Chem Lab Med; 2015 Feb; 53(2):257-63. PubMed ID: 25324455
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of two specific IgG immunoassays (HemosIL
Jousselme E; Guéry EA; Nougier C; Sobas F; Rollin J; Gruel Y; Vayne C; Pouplard C
Int J Lab Hematol; 2021 Jun; 43(3):468-476. PubMed ID: 33244896
[TBL] [Abstract][Full Text] [Related]
14. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
16. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
17. Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer.
Wong M; Oo TH; Qiao W; Garg N; Rojas-Hernandez CM
J Thromb Thrombolysis; 2017 Aug; 44(2):261-266. PubMed ID: 28677022
[TBL] [Abstract][Full Text] [Related]
18. Performance evaluation of heparin-induced platelet aggregation vs serotonin release assay.
Barouqa M; Matta M; Reyes-Gil M
Am J Clin Pathol; 2024 Feb; 161(2):122-129. PubMed ID: 37936260
[TBL] [Abstract][Full Text] [Related]
19. A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia.
Favaloro EJ; Mohammed S; Donikian D; Kondo M; Duncan E; Yacoub O; Zebeljan D; Ng S; Malan E; Yuen A; Beggs J; Moosavi S; Coleman R; Klose N; Chapman K; Cavanaugh L; Pasalic L; Motum P; Tan CW; Brighton T
Pathology; 2021 Feb; 53(2):247-256. PubMed ID: 33032809
[TBL] [Abstract][Full Text] [Related]
20. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
